Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development

B. Koletzko, C. Agostoni, S. E. Carlson, T. Clandinin, G. Hornstra, Martha Neuringer, R. Uauy, Y. Yamashiro, P. Willatts

    Research output: Contribution to journalArticle

    204 Citations (Scopus)

    Abstract

    This paper reports on the conclusions of a workshop on the role of long chain polyunsaturated fatty acids (LC-PUFA) in maternal and child health. The attending investigators involved in the majority of randomized trials examining LC-PUFA status and functional outcomes summarize the current knowledge in the field and make recommendations for dietary practice. Only studies published in full or in abstract form were used as our working knowledge base. Conclusions: For healthy infants we recommend and strongly support breastfeeding as the preferred method of feeding, which supplies preformed LC-PUFA. Infant formulas for term infants should contain at least 0.2% of total fatty acids as docosahexaenoic acid (DHA) and 0.35% as arachidonic acid (AA). Since preterm infants are born with much less total body DHA and AA, we suggest that preterm infant formulas should include at least 0.35% DHA and 0.4% AA. Higher levels might confer additional benefits and should be further investigated because optimal dietary intakes for term and preterm infants remain to be defined. For pregnant and lactating women we consider it premature to recommend specific LC-PUFA intakes. However, it seems prudent for pregnant and lactating women to include some food sources of DHA in their diet in view of their assumed increase in LC-PUFA demand and the relationship between maternal and foetal DHA status.

    Original languageEnglish (US)
    Pages (from-to)460-464
    Number of pages5
    JournalActa Paediatrica, International Journal of Paediatrics
    Volume90
    Issue number4
    StatePublished - 2001

    Fingerprint

    Docosahexaenoic Acids
    Unsaturated Fatty Acids
    Arachidonic Acid
    Premature Infants
    Infant Formula
    Pregnant Women
    Feeding Methods
    Knowledge Bases
    Breast Feeding
    Fatty Acids
    Mothers
    Research Personnel
    Diet
    Education
    Food

    Keywords

    • Arachidonic acid
    • Dietary requirements
    • Docosahexaenoic acid
    • Essential fatty acids
    • Infant nutrition

    ASJC Scopus subject areas

    • Pediatrics, Perinatology, and Child Health

    Cite this

    Koletzko, B., Agostoni, C., Carlson, S. E., Clandinin, T., Hornstra, G., Neuringer, M., ... Willatts, P. (2001). Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. Acta Paediatrica, International Journal of Paediatrics, 90(4), 460-464.

    Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. / Koletzko, B.; Agostoni, C.; Carlson, S. E.; Clandinin, T.; Hornstra, G.; Neuringer, Martha; Uauy, R.; Yamashiro, Y.; Willatts, P.

    In: Acta Paediatrica, International Journal of Paediatrics, Vol. 90, No. 4, 2001, p. 460-464.

    Research output: Contribution to journalArticle

    Koletzko, B, Agostoni, C, Carlson, SE, Clandinin, T, Hornstra, G, Neuringer, M, Uauy, R, Yamashiro, Y & Willatts, P 2001, 'Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development', Acta Paediatrica, International Journal of Paediatrics, vol. 90, no. 4, pp. 460-464.
    Koletzko, B. ; Agostoni, C. ; Carlson, S. E. ; Clandinin, T. ; Hornstra, G. ; Neuringer, Martha ; Uauy, R. ; Yamashiro, Y. ; Willatts, P. / Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development. In: Acta Paediatrica, International Journal of Paediatrics. 2001 ; Vol. 90, No. 4. pp. 460-464.
    @article{8092ec78f0e34685b49bf4d8afd8bc42,
    title = "Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development",
    abstract = "This paper reports on the conclusions of a workshop on the role of long chain polyunsaturated fatty acids (LC-PUFA) in maternal and child health. The attending investigators involved in the majority of randomized trials examining LC-PUFA status and functional outcomes summarize the current knowledge in the field and make recommendations for dietary practice. Only studies published in full or in abstract form were used as our working knowledge base. Conclusions: For healthy infants we recommend and strongly support breastfeeding as the preferred method of feeding, which supplies preformed LC-PUFA. Infant formulas for term infants should contain at least 0.2{\%} of total fatty acids as docosahexaenoic acid (DHA) and 0.35{\%} as arachidonic acid (AA). Since preterm infants are born with much less total body DHA and AA, we suggest that preterm infant formulas should include at least 0.35{\%} DHA and 0.4{\%} AA. Higher levels might confer additional benefits and should be further investigated because optimal dietary intakes for term and preterm infants remain to be defined. For pregnant and lactating women we consider it premature to recommend specific LC-PUFA intakes. However, it seems prudent for pregnant and lactating women to include some food sources of DHA in their diet in view of their assumed increase in LC-PUFA demand and the relationship between maternal and foetal DHA status.",
    keywords = "Arachidonic acid, Dietary requirements, Docosahexaenoic acid, Essential fatty acids, Infant nutrition",
    author = "B. Koletzko and C. Agostoni and Carlson, {S. E.} and T. Clandinin and G. Hornstra and Martha Neuringer and R. Uauy and Y. Yamashiro and P. Willatts",
    year = "2001",
    language = "English (US)",
    volume = "90",
    pages = "460--464",
    journal = "Acta Paediatrica, International Journal of Paediatrics",
    issn = "0803-5253",
    publisher = "Wiley-Blackwell",
    number = "4",

    }

    TY - JOUR

    T1 - Long chain polyunsaturated fatty acids (LC-PUFA) and perinatal development

    AU - Koletzko, B.

    AU - Agostoni, C.

    AU - Carlson, S. E.

    AU - Clandinin, T.

    AU - Hornstra, G.

    AU - Neuringer, Martha

    AU - Uauy, R.

    AU - Yamashiro, Y.

    AU - Willatts, P.

    PY - 2001

    Y1 - 2001

    N2 - This paper reports on the conclusions of a workshop on the role of long chain polyunsaturated fatty acids (LC-PUFA) in maternal and child health. The attending investigators involved in the majority of randomized trials examining LC-PUFA status and functional outcomes summarize the current knowledge in the field and make recommendations for dietary practice. Only studies published in full or in abstract form were used as our working knowledge base. Conclusions: For healthy infants we recommend and strongly support breastfeeding as the preferred method of feeding, which supplies preformed LC-PUFA. Infant formulas for term infants should contain at least 0.2% of total fatty acids as docosahexaenoic acid (DHA) and 0.35% as arachidonic acid (AA). Since preterm infants are born with much less total body DHA and AA, we suggest that preterm infant formulas should include at least 0.35% DHA and 0.4% AA. Higher levels might confer additional benefits and should be further investigated because optimal dietary intakes for term and preterm infants remain to be defined. For pregnant and lactating women we consider it premature to recommend specific LC-PUFA intakes. However, it seems prudent for pregnant and lactating women to include some food sources of DHA in their diet in view of their assumed increase in LC-PUFA demand and the relationship between maternal and foetal DHA status.

    AB - This paper reports on the conclusions of a workshop on the role of long chain polyunsaturated fatty acids (LC-PUFA) in maternal and child health. The attending investigators involved in the majority of randomized trials examining LC-PUFA status and functional outcomes summarize the current knowledge in the field and make recommendations for dietary practice. Only studies published in full or in abstract form were used as our working knowledge base. Conclusions: For healthy infants we recommend and strongly support breastfeeding as the preferred method of feeding, which supplies preformed LC-PUFA. Infant formulas for term infants should contain at least 0.2% of total fatty acids as docosahexaenoic acid (DHA) and 0.35% as arachidonic acid (AA). Since preterm infants are born with much less total body DHA and AA, we suggest that preterm infant formulas should include at least 0.35% DHA and 0.4% AA. Higher levels might confer additional benefits and should be further investigated because optimal dietary intakes for term and preterm infants remain to be defined. For pregnant and lactating women we consider it premature to recommend specific LC-PUFA intakes. However, it seems prudent for pregnant and lactating women to include some food sources of DHA in their diet in view of their assumed increase in LC-PUFA demand and the relationship between maternal and foetal DHA status.

    KW - Arachidonic acid

    KW - Dietary requirements

    KW - Docosahexaenoic acid

    KW - Essential fatty acids

    KW - Infant nutrition

    UR - http://www.scopus.com/inward/record.url?scp=0035055906&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0035055906&partnerID=8YFLogxK

    M3 - Article

    VL - 90

    SP - 460

    EP - 464

    JO - Acta Paediatrica, International Journal of Paediatrics

    JF - Acta Paediatrica, International Journal of Paediatrics

    SN - 0803-5253

    IS - 4

    ER -